
Cracks emerge in MAHA-MAGA alliance as RFK Jr. builds out his team of health ‘renegades'
The opulent ballroom of the Willard InterContinental Hotel is a regular stop on the high-dollar circuit of industry conferences that populate downtown Washington.
But on a recent morning, mingling among the marble columns was an eclectic group of outsiders new in town. Food influencers, organic farmers and anti-vaccine advocates were among those gathered for the official launch of the MAHA Institute, the latest incarnation of the Make America Healthy Again movement that has become a key facet of Washington in the second Trump administration.
Speakers took the stage to discuss medical freedom, school lunches, vaccine exemptions and above all, chronic illness. Farmers chatted about the importance of local produce but also the dangers of chemtrails in the sky. College students pitched a health startup built around the importance of 'touching grass.'
Speaking from the stage, Calley Means, a longtime ally of Health and Human Services Secretary Robert F. Kennedy Jr.'s who is now advising the White House, noted the oddity of pairing the people and ideas behind MAHA with those in Donald Trump's MAGA movement.
'There's a lot of organizations, a lot of people in this room who four to eight years ago, would have thought it was crazy to vote for President Trump,' Means said. 'And I think many of those same people in 2024 felt like their vote for President Trump was the most important vote of their life.'
With Trump came Kennedy, who nearly three months into the job as HHS secretary has finally built out his leadership team filled with Covid-19 contrarians and self-styled 'renegades.' Together, with the added influence of Elon Musk's Department of Government Efficiency, or DOGE, they've begun a massive overhaul of the nearly $3 trillion agency — implementing deep cuts in medical research and sweeping layoffs that have led to the departure of some of the most highly trained specialists working in the federal government.
Robert F. Kennedy Jr. grilled on his health policies by lawmakers
03:19
But agency shake-ups and new appointees have also begun to splinter the alliance between traditional Trump world allies and Kennedy's MAHA acolytes. Though it's early days, there is friction between the MAHA and MAGA camps, according to more than half a dozen current and former officials and people familiar with the conversations who declined to be named because they weren't authorized to speak on behalf of the health agency, or who feared retribution.
The White House bristled over the way Kennedy's team handled the measles outbreak in Texas and elsewhere this year. Meanwhile, Kennedy's powerful principal deputy chief of staff, Stefanie Spear, has cracked down on the way agency officials communicate publicly, insisting that she personally review statements and reports.
As for Kennedy's own leadership style, his oscillation between appeasing vaccine critics and placating public health officials has left people on both sides frustrated, multiple people familiar with the dynamics between the White House and HHS told CNN.
Cracks have also opened up within the MAHA movement itself. Tension spilled into public view this month as high-profile MAHA supporters railed against Trump's new pick for surgeon general, Calley Means' sister, Dr. Casey Means.
The holistic doctor has railed against the health care system's handling of chronic illnesses. But she has not discussed vaccine safety, and specifically Covid-19 vaccines, enough for some MAHA supporters.
Looming large is what many MAHA supporters — and Kennedy himself — have publicly described as years of dismissal and ostracization by the mainstream medical and scientific community. Now that they are in charge, their suspicion of the establishment has not abated.
'The number of actual, true MAHA supporters at the top of these agencies is maybe 75 people across an agency that has 60,000 employees,' Mark Gorton, MAHA Institute co-president and a tech entrepreneur, told the Willard ballroom. 'Their job is unbelievably daunting because these bureaucracies are highly resistant to change.'
But change is happening, buoyed by Kennedy's close circle of agency leaders and MAHA appointees.
According to one former official familiar with conversations inside HHS, despite being outnumbered, there is no question that it's the MAHA advocates who are now fully in charge of the government's health agencies.
'Anyone in power, who has any kind of control, is a MAHA person,' the former official said.
The MAHA movement is a key pillar of Trump's MAGA vision, White House spokesperson Kush Desai told CNN in a statement. 'Secretary Kennedy is both trusted and empowered by President Trump to deliver on his directive to get to the bottom of America's chronic disease epidemic, and this priority is shared not just by the White House and HHS, but the entire Trump administration.'
HHS did not respond to a request for comment.
RFK Jr.'s band of 'renegades'
To hear Kennedy describe it, there has never been unity like this among the country's top health officials.
'We're friends. We go to lunch together; we stay at each other's homes; we vacation together,' Kennedy told Fox News this month, flanked by the heads of three of the biggest health agencies: Dr. Marty Makary, Food and Drug Administration commissioner; Dr. Jay Bhattacharya, National Institutes of Health director; and Dr. Mehmet Oz, Centers for Medicare and Medicaid Services administrator.
'We're aligned in our vision. Friendship is based upon shared values, and that's the strongest bond that holds people together,' the secretary said. 'You got, sitting here, four people who are all canceled during Covid. The entire leadership of this agency is renegades, juggernauts against convention, and who are trying to look for truth, no matter what the cost.'
As he said, each of Kennedy's juggernauts became prominent critics of the government's Covid-19 response during shutdowns and vaccination efforts. It's a leadership group 'made for TV,' one former Trump health official told CNN.
Oz, known better by his TV moniker Dr. Oz, was already a public figure and adviser to Trump when the pandemic struck. He soon campaigned for reopening schools and touted hydroxychloroquine, without evidence, as an effective treatment for Covid-19 infection.
Bhattacharya was an early advocate of ending broad shutdowns, co-authoring an October 2020 paper that argued most young, healthy people could safely mingle and achieve herd immunity against the virus.
And while surgeon and author Makary supported certain public health measures during the pandemic, including early shutdowns and masking, his public opposition to vaccine mandates and skepticism of booster shots increasingly brought him into the circle of Covid-19 critics.
Each has been tasked with reorganizing their respective agencies and reorienting them toward a MAHA vision while satisfying cuts directed by DOGE, a sometimes discombobulated combination that has resulted in eliminating programs, research and staff.
Makary launched FDA initiatives to remove certain food dyes and reassess vaccine reviews. Bhattacharya is charged with leading Kennedy's massive autism research effort but also reworking the $48 billion NIH into merged groups with less funding. Oz has taken up the campaign for more artificial intelligence in health care outreach and defended potential Medicaid access requirements.
Friction over surgeon general pick
Yet outside the jovial unity of the country's top health officials, tensions are brewing about the assembly's commitment to MAHA goals. The debate broke open this month when Trump pulled Dr. Janette Nesheiwat for surgeon general, and tapped Casey Means to fill the role.
'The new Surgeon General has never called for the Covid shots to be pulled off the market. That's why she was picked,' Dr. Mary Talley Bowden, founder of Americans for Health Freedom, wrote on X. 'Kennedy is powerless.'
Nicole Shanahan, Kennedy's former running mate in his 2024 independent presidential bid, also questioned the choice, suggesting on X that the HHS secretary may be 'reporting to someone regularly who is controlling his decisions (and it isn't President Trump).'
More recently, Shanahan took more precise aim at Kennedy's MAHA moves thus far, targeting food dyes but not — in her mind — putting sufficient pressure on issues including Covid-19 vaccines. 'Sure, we can make Fruit Loops great again, but let's not overlook the bigger issues—glyphosate and mRNA,' she wrote on X.
The blowback has led Kennedy himself to step in and defend Means, a holistic medicine doctor who rose to prominence after she and her brother linked up with the MAHA movement and Kennedy's presidential campaign.
'Appointing Casey Means as US Surgeon General is like appointing someone who dropped out of West Point as Chairman of the Joint Chiefs of Staff,' Steve Kirsch, an anti-Covid vaccine advocate and tech entrepreneur, wrote on X the afternoon of May 10.
Five hours later, Kirsch posted his change of heart: 'I've talked to RFK and now support her despite my initial reservations.'
Divisions inside HHS
Outside of layoffs and reassignments at HHS, droves of federal employees have left the agency, several citing frustrations with the new leadership and Kennedy's chief of staff, Spear, a former environmental journalist who joined Kennedy's presidential campaign as press secretary.
Spear told staff in meetings that all external communications, including responses to press but also routine reports such as the Centers for Disease Control and Prevention's weekly mortality updates or articles submitted by the NIH to research journals, would need to be reviewed by her, according to four people familiar with the meetings.
Spear also controls the communications and information that Kennedy receives, according to those people.
'She's probably one of the biggest challenges of him getting feedback of any kind, information from the team,' said a former official who recently left the agency. 'Everything is filtered through her.'
The slowdown on communications left White House officials frustrated with HHS' early response to the ongoing measles outbreak, that person and others familiar with the conversations said.
White House officials would call HHS staff asking about the measles response, only to be told that Spear was handling it, the former officials said. There are now more than 1,000 measles cases across 30 states, according to CDC figures. Kennedy told congressional committees last week that 'we've handled this measles outbreak better than any other nation.'
Frustrations with Kennedy's assembled leadership and the health agency overhaul have only exacerbated the flood of experts leaving HHS.
For instance, so many people have left the agency's legal office that there is anxiety about whether HHS has the staff to man the looming battles with Harvard University over frozen research grants, the former official and another person familiar said.
It is 'an utter disaster,' said the person familiar.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
First PRIZM Study Participant Enrolled in Tisento Therapeutics' Open-Label Extension Study in MELAS
Participants Who Complete Treatment in Global Phase 2b PRIZM MELAS Study Are Eligible to Enroll CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the first participant has enrolled in the company's open-label extension study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes). The extension study (NCT06961344) is evaluating the long-term safety and tolerability of zagociguat in individuals with MELAS who complete treatment in the global Phase 2b PRIZM study, which is expected to complete screening in the next months. The extension study is intended to provide uninterrupted access to zagociguat for clinical trial participants for up to two years and evaluate the long-term safety of zagociguat. 'We're pleased to reach the important milestone of enrolling the first PRIZM study participant into our open-label extension study,' said Peter Hecht, Ph.D., chief executive officer of Tisento. 'Enthusiastic engagement by MELAS patients and physicians is powering momentum in our development program, and we look forward to completing PRIZM enrollment in the next few months.' The PRIZM study is actively enrolling in the U.S., Canada, Australia, United Kingdom, Italy, and Germany, and interested individuals are encouraged to discuss participation with their physician. PRIZM is evaluating the impact of zagociguat treatment on fatigue, cognitive performance, and other key aspects of MELAS. The clinical outcome assessments and endpoint strategy for the PRIZM study were informed by Tisento's interview study in which individuals living with MELAS described the symptoms and impacts of the disease that are most important to them. Participants who complete treatment in PRIZM have the opportunity to enroll in the open-label extension study. About the PRIZM Study PRIZM – a Phase 2b Randomized, Placebo-Controlled Trial Investigating Zagociguat in MELAS – is evaluating the efficacy and safety of oral zagociguat 15 mg or 30 mg compared to placebo when administered once-daily for 12 weeks in participants with genetically and phenotypically defined MELAS. The PRIZM study has a crossover design, with two 12-week treatment periods separated by a 4-week washout period. All participants will receive zagociguat during one of the 12-week periods and placebo during the other. Participants who complete treatment in the study have the opportunity to enroll in an open-label extension study. The global PRIZM study is now enrolling approximately 44 participants at mitochondrial disease centers of excellence in the U.S., Italy, Germany, United Kingdom, Australia, and Canada. For more information, please visit or (NCT06402123). Interested individuals can also reach out to their physicians for participation details. About Zagociguat Zagociguat is a once-daily, oral, clinical-stage investigational medicine with potential to positively impact both peripheral and central nervous system manifestations of mitochondrial diseases. Zagociguat stimulates soluble guanylate cyclase (sGC), an enzyme that is found in virtually every cell in every tissue of the body and is part of a system of cellular mechanisms that control critical physiological functions including neuronal function and blood flow. A first-in-class, brain-penetrant sGC stimulator, zagociguat is hypothesized to rebalance dysregulated cellular pathways in MELAS. By restoring cellular functions that support mitochondria, zagociguat may help restore mitochondrial energy production and physiological function. In a Phase 2a study in patients with MELAS, zagociguat exhibited a favorable safety profile, exposure throughout the body including in the central nervous system, and improvements in neuronal function, mitochondrial function, and blood flow in the brain. Zagociguat is currently being evaluated as a treatment for MELAS in the Phase 2b PRIZM study. Zagociguat received Fast Track designation from the U.S. Food and Drug Administration for the treatment of MELAS. Fast Track is a process designed to facilitate the development and potentially expedite the review of medicines to treat serious conditions and fill an unmet medical need, with the goal of getting important new drugs to patients earlier. For more information, visit About Tisento Therapeutics Tisento Therapeutics, a privately held biotech company, is developing novel medicines to treat diseases with significant unmet need, beginning with MELAS and other genetic mitochondrial diseases. Ti sento means 'I hear you' in Italian; our approach to innovation begins with listening to patients and then channeling what we learn into decisive actions that shape our research and clinical programs. Tisento is guided by a high-caliber internal team of biopharma veterans and an extensive external network of expert physicians, patient advocacy groups, researchers, industry-leading vendors, and other close collaborators who are partners in our mission to develop meaningful treatments for mitochondrial diseases. Learn more at our website, or connect with us on LinkedIn, Facebook, X (@tisentotx), or Bluesky. Contact Tisento Media RelationsJessi Rennekamp, Astrior CommunicationsEmail: jessi@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
This Advice From Economics Might Be The Answer To Your Parenting Burnout. Here's Why.
When my wife and I brought our first child home from the hospital, we planned on diligently following all of the expert recommendations regarding his care: He would breastfeed exclusively and sleep in a bassinet beside our bed, on his back, in a properly ventilated room. We had read about SIDS and would take every possible precaution. What could be more important that preventing harm from coming to our child? Almost immediately, however, we ran into trouble. Our baby stopped peeing. He was dehydrated and hungry, somehow, although he spent pretty much all day at my breast. So we feed him some infant formula using a medicine dropper, which he lapped up hungrily, sending me into a shame spiral that took months of therapy to crawl out of. But at least with the supplementary formula we were able to keep him happily fed. Related: The second problem sent us into a territory that was even more mortifying. In spite of the fact that my breasts were only partially functional, the baby was extremely attached to them. As in, he would only sleep if they were right there, right beside him, skin to skin with his tiny cheek. Every time he feel asleep while nursing and unlatched his little rosebud lips, I moved as stealthily as possible to try to get him into the bassinet. But more often than not, he woke and started crying. And even if I could get him to lie in the bassinet, it often didn't last long. The end result was that I spent a lot of time nursing him in the chair, and, in my desperation and exhaustion, I often fell asleep. My wife could tell, just by looking at us, that this was not a safe situation. Since it wasn't possible to get him into the bassinet, we just cleared our bed of blankets and pillows and let him sleep where he wanted to, right next to my body. We didn't tell anyone. We had been taught that bed-sharing with a baby was deadly, so we certainly weren't going to admit to doing it. This was all back in 2009, before economist Emily Oster began publishing her bestselling books, in which she brings a unique, data-driven perspective to the art of parenting. In her second book, 'Cribsheet,' she explains how holding up the ideal infant sleeping arrangement as the only permissible option can actually lead parents to put their babies in more danger. Because although it is safest to have baby sleep on a separate surface, it is much more dangerous to sleep with a baby on a sofa or armchair. Sixty-seven times more dangerous. Though it wasn't a best-case scenario that the baby wasn't in the bassinet, he was a lot safer sleeping next to me on the mattress instead of in the recliner. Infant sleep, Oster writes, is one example of a scenario in which we might benefit from considering what she calls 'second best' parenting. It is a term she borrows from economics. 'When we are giving advice in parenting, we tend to be absolutist: There is the best option and then everything else,' Oster told HuffPost, She has used the term 'outer darkness' to refer to everything else — as in, if it's not the best option, it's all equally bad and scary. But this all-or-nothing approach doesn't apply well to infant sleep, where we clearly have a first best option (bassinet/crib in same room as parent) followed by a second best option (on a clear, flat sleeping surface next to the nursing parent) and then, way, way down, the 67th best option of a desperate mother accidentally falling asleep in an armchair while holding the baby because she has been told that under no circumstances should she consider bringing the baby into her bed. 'The idea of 'second best' is to recognize that within the category of 'other options,' some are better than others. The second best is the best option that we can achieve,' Oster said. She thinks that this can be a useful framework for other parenting choices, too, such as what to feed our children. 'We're told the best snack for our kids is, say, a whole apple and a glass of water. But what if your kid doesn't eat that? We don't help people pick well among the options their child will eat. You'd be forgiven for thinking that once you're going to applesauce, you might as well give a pile of cookies. But actually those aren't the same.' Believing that there is only one right way and the rest are wrong sets us up to see only black and white when actually there are so many shades of gray. 'When we tell people that it's the 'best or the rest,' we do not allow for them to choose smartly among the rest,' Oster said. In addition to not choosing well, this thinking makes people feel badly about how they're parenting. 'When we tell people they aren't doing their best, that disempowers them. And no one parents well from a place of shame,' Oster added. Finding Other Good Options Beyond Perfect The advantage of referring to 'second best' is that, with the word 'best,' parents are left with space to take pride in their parenting. A silver or bronze medal is still a win, after all. The argument that Oster is making is similar to that of 'good enough parenting,' an idea popularized in the 1950s by Donald Winnicott. Parenting coach Kristene Geering told HuffPost that this is the framework she uses with parents. 'It's based on the notion that there is no such thing as perfect,' Geering explained. 'Part of being human is that there are challenges, there are times when there's no clear or easy path (which is also how we learn). There is no 'best.' You take what information you have, make a decision based on that and then you learn as you go along.' Geering thinks this dovetails nicely with Carol Dweck's 'growth mindset,' in which as we learn more, we do better. Geering said she often tells families that 'we're all doing the best we can with what we have' and advises, 'Learn from your mistakes, repair as you go, and show your children how to hold compassion for yourself and those around you.' She likes the 'good enough' phrasing because it makes room for the idea that there are many different options that might be 'bests' for different families dealing with different circumstances. Geering agrees with Oster that it's important to move parents out the space of 'all is lost,' where they may get trapped in their shame. She said that where she works in Silicon Valley, 'I see a lot of parents fall into this trap of trying to be 'perfect' ... and then researching themselves into a state where they're almost frozen with indecision.' With an endless amount of information readily available, this isn't an uncommon place for parents to land. 'I've fallen into this trap as well,' Geering admitted. 'Things like which school to attend, which activity to sign up for... it's really overwhelming.' Make Peace With Your 'Good Enough' Using a 'second best' or 'good enough' mindset doesn't come naturally to people raised in a culture of competition. But sooner or later, all parents are faced with a scenario that challenges expectations of perfection. For Geering, a clear example of this in her own family was pandemic schooling. 'I watched my own kids struggle on 'Zoom school,' to the point where it was clear this would never work for them. So I pulled them, and we did homeschool for a year... while my husband and I both worked full time. Was it perfect? Nope. Was it 'second best'? I have no idea.' Her kids are 'still catching up on math,' she said, although they also 'gained a lot of skills in independence.' 'Instead of beating myself up on all the math they missed out on, I looked at it from the point of view that I was doing the best I could in really awful circumstances. And I looked at all the moms in my friend groups and the parents I was working with, and I saw everyone making different decisions, based on their specific circumstances. Absolutely no one did the 'best' thing... because there was no 'best' thing.' Whether you think of it as 'second best' or 'good enough,' parenting within this framework, as opposed to one in which there is only one right option for all families, makes room for you to give yourself some grace. An added benefit of letting go of a perfection-or-nothing mindset is the weight that this takes off of our kids. If we 'show them how to repair the relationship when we mess up and share our learning process with them,' Geering said, 'it lets them be compassionate with themselves, learn from their mistakes, create authentic and meaningful relationships with others, and have a growth mindset as their default throughout life. That's pretty powerful stuff.' Related... Parents Are Lying About Where Their Babies Sleep At Night. Here's Why That's A Problem. What Second-Time Parents Wish They Didn't Stress About The First Time Around This 1 Thing May Be Wearing Parents Out Everywhere


Medscape
21 minutes ago
- Medscape
AAP Counters ACIP Guidance in New Immunization Schedule
America's leading professional pediatric association has released its latest immunization schedule, contravening current federal COVID-19 immunization guidance. The immunization schedule was published on August 19 in the American Academy of Pediatrics (AAP)'s Redbook Online and calls for universal COVID-19 immunization beginning at 6 months. It also includes the group's formal recommendations for routine infant, children, and adolescent immunizations against 18 diseases. There are also updated recommendations for respiratory syncytial virus and influenza. 'We extensively reviewed the most recently available data about COVID-19 risks in kids, as well as safety and effectiveness of available COVID-19 vaccines. It's clear they are very safe for all populations,' Sean O'Leary, MD, chair of the AAP Committee on Infectious Diseases, said in a statement. In May of this year, Health and Human Services Secretary, Robert F. Kennedy, Jr, announced in a video posted on X, that the CDC had dropped Biden era recommendations that all pregnant women and children be given the COVID-19 vaccine. The video came on the heels of the CDC's announcement that only 13% of eligible children were up to date on their COVID-19 vaccine. In children aged 6 months to 23 months, that number was about 5%. 'Evidence-Based' vs 'Conflict of Interest' The AAP said its COVID-19 recommendations are 'evidence-based' and that they 'differ from recent recommendations of the Advisory Committee on Immunization Practices of the CDC, which was overhauled this year and replaced with individuals who have a history of spreading vaccine misinformation.' Kennedy's office shot back that the AAP is not acting in good faith. 'By bypassing the CDC's advisory process and freelancing its own recommendations, while smearing those who demand accountability, the AAP is putting commercial interests ahead of public health and politics above America's children,' Kennedy's Communications Director, Andrew Simpson, said in a statement provided to Medscape Medical News . Kennedy's office continued, 'The American people deserve confidence that medical recommendations are based solely on science and public health. We call on the AAP to strengthen conflict-of-interest safeguards and keep its publications free from financial influence, ensuring every recommendation reflects only the best interests of America's children.' COVID-19 The Academy noted that because it can be fatal in children, especially those aged 6 months through 23 months; it recommends a COVID-19 vaccine for this patient population, unless they have a known allergy to the ingredients of the vaccine. An age-appropriate COVID-19 vaccine is recommended for all children and adolescents 2 through 18 years of age in the following risk groups: Persons at high risk for severe COVID-19 Residents of long-term care facilities or other congregate settings Persons who have never been vaccinated against COVID-19 Persons whose household contacts are at high risk for severe COVID-19 The most updated version of the vaccine should be made available to any parent or guardian who desires their child to be protected against COVID-19, according to the Academy's recommendations. The AAP's COVID-19 vaccine guidelines are published online and will be published in the November issue of Pediatrics . 'Among the reasons we decided to move to a risk-based recommendation for healthy older children is the fact that the hospitalization rate for young children and children underlying medical conditions remains high, in line with rates for many of the other vaccine-preventable diseases for which we vaccinate,' O'Leary said. Federal recommendations state that the COVID-19 shot is not universally recommended, but that physicians take a case-by-case approach in pediatric cases. Adults aged 18 years or older are still advised to receive the vaccine under this administration. 'Rooted in Science' The AAP's other vaccine recommendations largely mirror those of ACIP. The new schedule also addresses recent updates on pentavalent meningococcal vaccine, the starting age of the human papilloma virus vaccine, and the removal of a hepatitis vaccine that is no longer available, according to the statement. 'The AAP will continue to provide recommendations for immunizations that are rooted in science and are in the best interest of the health of infants, children, and adolescents,' AAP President Susan J. Kressly, MD, said in the statement. 'Pediatricians know how important routine childhood immunizations are in keeping children, families, and their communities healthy and thriving.' Insurance Coverage in Question Insurance coverage for vaccinations is normally based on federal recommendations. Now that there is a schism in recommendations, coverage is in question. 'The AAP urges every insurer to cover all the vaccines that are included in this immunization schedule,' Kressly said in the statement. 'AAP is committed to working with our partners at the local, state, and federal levels to make sure every child, in every community, has access to vaccines.'